A Study Evaluating Nexagon™ in the Treatment of Skin Wounds.

NCT00736593 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

OcuNexus Therapeutics, Inc.